Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

12-15 November, 2019
RAI Amsterdam,
Amsterdam, Netherlands

Increase half-life and minimise manufacturing costs through new data, case studies and technologies for peptide therapeutics

TIDES Europe 2018 was a success!

Thank you to all of the attendees who made this year's show the largest one yet. Mark your calendar for next year's show, held 12-15 November 2019 at the RAI in Amsterdam.

ACCESS THE 2018 ATTENDEE LIST


All 2018 registered attendees have access to the 2018 attendee list through the TIDES Europe Networking App.  If you cannot locate your log-in credentials, please contact chisom.fadeyi@knect365.com.

The App will be available through the end of the year

Check out the topics that were covered at the 2018 meeting

Discovery & R&D
  • New frontiers in peptide therapeutics – Where are the future opportunities?
  • Explore the latest selection and screening technologies for lead discovery
  • Improve drug-like properties of next generation peptide therapeutics: Lead optimisation and engineering strategies
  • Implement cost of goods modelling to evaluate potential drug candidates
Delivery & Clinical Updates
  • What are the most exciting peptides advancing through the clinic?
  • Get top tips learnt from preclinical and clinical development
  • Examine the latest advances in oral peptide therapeutics
  • Stay on top of new techniques for improved administration of peptide products
Manufacturing & CMC
  • Delve into strategies to reduce cost of goods and improve manufacturing efficiency
  • Master process development and scale up of complex peptide therapeutics
  • Discover how enzymatic synthesis and continuous flow can be applied to large scale production
  • Uncover analytical methods to identify and characterise peptide impurities

GAIN THE SCIENCE, TECHNOLOGIES AND CONTACTS YOU NEED TO ACCELERATE PEPTIDE THERAPEUTICS TO MARKET

300+
OLIGONUCLEOTIDE AND PEPTIDE SCIENTISTS AND EXECUTIVES
40+
CASE STUDIES AND NEW DATA PRESENTATIONS
30+
LEADING EXHIBITORS

Thank you to our EuroPEPTIDES 2018 Scientific Advisory Board

  • Waleed Danho, Former, Distinguished Research Leader, Roche, USA
  • Bruce Morimoto, Executive Director, Applied Translational Medicine, Celerion, USA
  • Thomas Meier, Chief Operations Officer, Bachem Europe, Switzerland
  • Jesper Lau, Vice President, Diabetes Protein & Peptide Chemistry, Novo Nordisk, Denmark
  • Joel Richard, Senior Vice President, Peptides - Head of CMC Development, Ipsen, France
  • Neil Thompson, Director Business Development, PolyPeptide
  • Leila Malik, CMC Project Manager, Zealand Pharma
  • Michael Postlethwaite, Program and Business Development Manager, Bachem, Switzerland

PARTNERING OPPORTUNITIES AT EuroPEPTIDES 2019


Highlight your company's expertise to 300+ scientists and key decision makers working across peptide & oligonucleotide development.  A wide variety of options are available to accommodate your company's goals and budget.